Is it mandatory for a C2 hard copy prescription to have the pharmacist or practitioner's signature on the face of the prescription?

In the context of Nebraska pharmacy law and regulations regarding controlled substances, the correct rationale for the requirement on the presence of a signature on C2 prescriptions stems from historical changes in legal mandates. The requirement for a pharmacist or practitioner's signature on the face of a hard copy prescription for Schedule II controlled substances has been modified, reflecting legislative updates and shifts in practice standards.

Specifically, there was a point in time when such signatures were indeed mandatory, but recent amendments and reforms have reduced that necessity. This allows for more streamlined processing of prescriptions, especially with the increasing reliance on electronic prescriptions, which do not typically necessitate a handwritten signature.

The other choices may imply either a misunderstanding of the current law or a misinterpretation of who is responsible for verifying prescriptions. Since the regulation has explicitly moved forward and removed the requirement for the signature under certain conditions, the correct understanding hinges on recognizing that this change reflects broader trends in digitalization and regulatory evolution in pharmacy practices.